Bangkok Dusit Medical Stock Current Valuation
| BDULFDelisted Stock | USD 0.73 0.00 0.00% |
Valuation analysis of Bangkok Dusit Medical helps investors to measure Bangkok Dusit's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Bangkok Dusit's price fluctuation is very steady at this time. Calculation of the real value of Bangkok Dusit Medical is based on 3 months time horizon. Increasing Bangkok Dusit's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bangkok pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Bangkok Dusit Medical. Since Bangkok Dusit is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bangkok Pink Sheet. However, Bangkok Dusit's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.73 | Real 0.64 | Hype 0.73 |
The real value of Bangkok Pink Sheet, also known as its intrinsic value, is the underlying worth of Bangkok Dusit Medical Company, which is reflected in its stock price. It is based on Bangkok Dusit's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bangkok Dusit's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bangkok Dusit Medical helps investors to forecast how Bangkok pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bangkok Dusit more accurately as focusing exclusively on Bangkok Dusit's fundamentals will not take into account other important factors: Bangkok Dusit Medical Company Current Valuation Analysis
Bangkok Dusit's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Bangkok Dusit Current Valuation | 13.03 B |
Most of Bangkok Dusit's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bangkok Dusit Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Bangkok Dusit Medical has a Current Valuation of 13.03 B. This is 9.28% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current valuation for all United States stocks is 21.62% higher than that of the company.
Bangkok Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bangkok Dusit's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Bangkok Dusit could also be used in its relative valuation, which is a method of valuing Bangkok Dusit by comparing valuation metrics of similar companies.Bangkok Dusit is currently under evaluation in current valuation category among its peers.
Bangkok Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0739 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 13.03 B | |||
| Shares Owned By Institutions | 8.46 % | |||
| Price To Earning | 50.79 X | |||
| Price To Book | 4.91 X | |||
| Price To Sales | 0.14 X | |||
| Revenue | 74.45 B | |||
| Gross Profit | 24.99 B | |||
| EBITDA | 17.64 B | |||
| Net Income | 7.94 B | |||
| Cash And Equivalents | 16.66 B | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 12.5 B | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 5.41 X | |||
| Cash Flow From Operations | 14.56 B | |||
| Earnings Per Share | 0.02 X | |||
| Number Of Employees | 45 | |||
| Beta | 0.43 | |||
| Market Capitalization | 13.53 B | |||
| Total Asset | 128.45 B | |||
| Retained Earnings | 28.38 B | |||
| Working Capital | (3.49 B) | |||
| Current Asset | 12.76 B | |||
| Current Liabilities | 16.25 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 128.45 B | |||
| Last Dividend Paid | 0.5 |
About Bangkok Dusit Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bangkok Dusit Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bangkok Dusit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bangkok Dusit Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Bangkok Pink Sheet
If you are still planning to invest in Bangkok Dusit Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bangkok Dusit's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |